Clinical Trial: A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07015437) titled 'A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1' on April 28.

Brief Summary: The objective of this trial is to assess the post-infusion viability of INTERCEPT RBCs by measuring the 24-hour post-infusion recovery and lifespan of autologous RBCs prepared with the INTERCEPT Blood System for RBC with AS-1 after 35 days post collection storage in comparison to untreated AS-1 RBCs stored for 35 days.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DEVICE: INTERCEPT Blood System for RBCs

RBCs treated with the INT...